| Lora Chatmon, MS/CCC/SLP | |
|
1010 Christine Ave, Suite 250, Anniston, AL 36207-5782 | |
| (256) 235-3050 | |
| Not Available |
| Full Name | Lora Chatmon |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1010 Christine Ave, Anniston, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902046469 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | AL 2147 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lora Chatmon, MS/CCC/SLP 1010 Christine Ave, Suite 250, Anniston, AL 36207-5782 Ph: (256) 235-3050 | Lora Chatmon, MS/CCC/SLP 1010 Christine Ave, Suite 250, Anniston, AL 36207-5782 Ph: (256) 235-3050 |
News Archive
Autism and cancer share more than 40 risk genes, suggesting that common mechanisms underlying the functions of some of these genes could conceivably be leveraged to develop therapies not just for cancer but for autism as well, an extensive assessment by researchers with the UC Davis MIND Institute and Comprehensive Cancer Center has found.
A team of U.S., Canadian and Italian scientists led by researchers at Johns Hopkins report evidence from studies in animals and humans supporting a link between Alzheimer's disease and chronic heart failure, two of the 10 leading causes of death in the United States.
Maren Roman is taking nanocrystal research to a new level that may lead to a new generation of vaccines and better computer printer ink.
The full characterization of biotherapeutics is required by regulatory authorities as properties such as safety, efficacy and the serum half-life of therapeutic proteins can be affected by differences in their glycosylation pattern. Recombinant monoclonal antibody therapeutics (mAbs) represent the largest group of therapeutic proteins the analysis of the glycan pattern is therefore an essential part of the mAb characterization process.
What medications can be used to treat lung cancer, and how effective are they? Until now, drug companies have had to rely on animal testing to find out. But in the future, a new 3D model lung is set to achieve more precise results and ultimately minimize - or even completely replace - animal testing. From June 23-26, researchers will be presenting their new model at the BIO International Convention in San Diego, California (Germany Pavilion, Booth 4513-03).
› Verified 5 days ago
Amanda Marable, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 415 Castle Ave, Anniston, AL 36205 Phone: 256-237-8203 Fax: 256-235-2388 | |
Caroline Brook, MS, SLP-CF Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 731 Leighton Ave, Anniston, AL 36207 Phone: 256-235-5155 Fax: 256-235-5590 | |
Julie M Rismiller, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 400 E 10th St, Anniston, AL 36207 Phone: 256-235-5860 | |
Ashley Kym Smart, MCD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1910 Coleman Rd, Anniston, AL 36207 Phone: 256-240-8801 | |
Mrs. Rena D. Schoenberg, M. A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1265 Ravenwood Dr, Anniston, AL 36207 Phone: 256-239-1335 | |
Savannah Taylor, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3331 Henry Road, Anniston, AL 36207 Phone: 256-624-6377 | |
Deborah Mcbee, M.S.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2300 Coleman Rd, Anniston, AL 36207 Phone: 256-831-5730 |